Controls for reverse transcriptase-polymerase chain reaction amplification of BCR-ABL transcripts.
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to X H Yan.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Purified human hepatitis B immunoglobulin (HBIG) was complexed to plasma derived hepatitis B vaccine (HBVac) at different concentrations and used to immunize Balb/c mice. An enhanced humoral immune response was observed when HBVac was complexed to HBIG in excess of antigen, compared to that immunized with the vaccine alone. Proliferation of splenic lymphocytes was detected when mice were immunized with HBIG complexed to HBVac (0.2-1 microgram), whereas in mice immunized only with HBVac at one microgram, no lymphocyte proliferation was observed. The enhanced immunogenicity of HBIG: HBVac is T cell dependent. The importance of using critical ratio of HBIG and HBVac is indicated, and future application of this complex for vaccination of low- or nonresponders to the present HBVac, as well as for treatment of chronic hepatitis B patients is discussed.
Seventy patients with clonorchis sinensis infection were divided randomly into two groups and treated with levo-praziquantel and praziquantel in the same dosage of 12.5 mg/kg twice a day for two consecutive days (total dosage of 75 mg/kg). Follow-up stool examination three and six months after treatment showed that the egg negative conversion rates with levo-praziquantel group were 92.86% and 92.59%, while those of praziquantel group were 58.62% and 53.57% respectively. The results showed that levo-praziquantel was significantly superior to praziquantel (P < 0.001). The side reactions in both group were mild and transient.
Explore the source record for details and available documents.
Explore the source record for details and available documents.